Lyubov Moysik
Family Medicine · Brooklyn, NYNPI 1053429167
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 455 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,410 and has fallen 99.3% since, to $17 in 2024. Among family medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 455 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$924
- Amgen$918
- GSK$857
- Novartis$792
- Merck$611
- plus $4K from 28 others
What the payments were for
- Food & beverage$9,347100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 62 | $1,364 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 42 | $924 |
| Amgen(2 entities) | 41 | $918 |
| GSK | 35 | $857 |
| Novartis | 48 | $792 |
| Merck | 27 | $611 |
| AstraZeneca | 24 | $432 |
| Scilex Pharmaceuticals Inc. | 19 | $409 |
| Lilly USA, LLC | 22 | $364 |
| Amarin Pharma, Inc. | 18 | $344 |
| Cumberland Pharmaceuticals, Inc. | 16 | $298 |
| Boehringer Ingelheim | 15 | $292 |
| Bayer | 12 | $282 |
| Pfizer | 15 | $278 |
| Endo Pharmaceuticals Inc. | 9 | $192 |
| Vivus LLC | 6 | $111 |
| Ironwood Pharmaceuticals, Inc | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Almatica Pharma LLC | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Nestle Healthcare Nutrition Inc. | 3 | $76 |
| Arbor Pharmaceuticals, Inc. | 4 | $65 |
| Mylan Specialty L.p. | 3 | $63 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| Alkermes, Inc. | 2 | $41 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Johnson & Johnson | 2 | $36 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Astellas Pharma US Inc | 2 | $30 |
| Incyte Corporation | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Shield Therapeutics Inc | 1 | $23 |
| Sebela Pharmaceuticals Inc. | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,347 in reported general payments places this provider in the 90th percentile of 4,321 family medicine providers in New York.
Other family medicine in Brooklyn
- Walford LindoBrooklyn$104K
- Fu Fu HeBrooklyn$101K
- Jonathan ChangBrooklyn$66K
- Rui TengBrooklyn$39K
- Wei WangBrooklyn$26K
- Raymond ChanBrooklyn$25K
- Mikhail KorogluyevBrooklyn$24K
- Louis BonavitaEast Syracuse$674K
- Martin MahoneyBuffalo$520K
- Scott BrehautClinton$514K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.